Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 457 to 461 of 461 entries
Sorted by: Best Match Show Resources per page
Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: a new analytical approach to overcome the limitations of correlation-based methods.

Diabetic medicine : a journal of the British Diabetic Association

Camerlingo N, Vettoretti M, Sparacino G, Facchinetti A, Mader JK, Choudhary P, Del Favero S.
PMID: 34862829
Diabet Med. 2021 Dec 04;e14758. doi: 10.1111/dme.14758. Epub 2021 Dec 04.

AIMS: Reliable estimation of the time spent in different glycemic ranges (time-in-ranges, TIRs) requires sufficiently long continuous glucose monitoring (CGM). In a 2019 paper (Battelino et al., Diabetes Care, 2019), an international panel of experts suggested using a correlation-based...

Cite
Camerlingo N, Vettoretti M, Sparacino G, et al. Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: a new analytical approach to overcome the limitations of correlation-based methods. Diabet Med. 2021;e14758doi: 10.1111/dme.14758.
Camerlingo, N., Vettoretti, M., Sparacino, G., Facchinetti, A., Mader, J. K., Choudhary, P., Del Favero, S. (2021). Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: a new analytical approach to overcome the limitations of correlation-based methods. Diabetic medicine : a journal of the British Diabetic Association, e14758. https://doi.org/10.1111/dme.14758
Camerlingo, Nunzio, et al. "Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: a new analytical approach to overcome the limitations of correlation-based methods." Diabetic medicine : a journal of the British Diabetic Association vol. (2021): e14758. doi: https://doi.org/10.1111/dme.14758
Camerlingo N, Vettoretti M, Sparacino G, Facchinetti A, Mader JK, Choudhary P, Del Favero S. Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: a new analytical approach to overcome the limitations of correlation-based methods. Diabet Med. 2021 Dec 04;e14758. doi: 10.1111/dme.14758. Epub 2021 Dec 04. PMID: 34862829.
Copy Download .nbib Format: NLM
Dose reduction potential in diagnostic single energy CT through patient-specific prefilters and a wider range of tube voltages.

Medical physics

Steidel J, Maier J, Sawall S, Kachelrieß M.
PMID: 34796532
Med Phys. 2022 Jan;49(1):93-106. doi: 10.1002/mp.15355. Epub 2021 Dec 10.

PURPOSE: Various studies have demonstrated that additional prefilters and/or reduced tube voltages have the potential to significantly increase the contrast-to-noise ratios at unit dose (CNRDs) and thereby to significantly reduce patient dose in clinical CT. An exhaustive analysis, accounting...

Cite
Steidel J, Maier J, Sawall S, et al. Dose reduction potential in diagnostic single energy CT through patient-specific prefilters and a wider range of tube voltages. Med Phys. 2021;49(1):93-106doi: 10.1002/mp.15355.
Steidel, J., Maier, J., Sawall, S., & Kachelrieß, M. (2022). Dose reduction potential in diagnostic single energy CT through patient-specific prefilters and a wider range of tube voltages. Medical physics, 49(1), 93-106. https://doi.org/10.1002/mp.15355
Steidel, Jörg, et al. "Dose reduction potential in diagnostic single energy CT through patient-specific prefilters and a wider range of tube voltages." Medical physics vol. 49,1 (2022): 93-106. doi: https://doi.org/10.1002/mp.15355
Steidel J, Maier J, Sawall S, Kachelrieß M. Dose reduction potential in diagnostic single energy CT through patient-specific prefilters and a wider range of tube voltages. Med Phys. 2022 Jan;49(1):93-106. doi: 10.1002/mp.15355. Epub 2021 Dec 10. PMID: 34796532.
Copy Download .nbib Format: NLM
Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.

Cell death & disease

Maier JP, Ravi VM, Kueckelhaus J, Behringer SP, Garrelfs N, Will P, Sun N, von Ehr J, Goeldner JM, Pfeifer D, Follo M, Hannibal L, Walch AK, Hofmann UG, Beck J, Heiland DH, Schnell O, Joseph K.
PMID: 34290229
Cell Death Dis. 2021 Jul 21;12(8):723. doi: 10.1038/s41419-021-03937-9.

Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by its dynamic response to microenvironmental niches. In particular, this cellular plasticity contributes to the development of an immediate resistance during tumor treatment. Novel insights into...

Cite
Maier JP, Ravi VM, Kueckelhaus J, et al. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell Death Dis. 2021;12(8):723doi: 10.1038/s41419-021-03937-9.
Maier, J. P., Ravi, V. M., Kueckelhaus, J., Behringer, S. P., Garrelfs, N., Will, P., Sun, N., von Ehr, J., Goeldner, J. M., Pfeifer, D., Follo, M., Hannibal, L., Walch, A. K., Hofmann, U. G., Beck, J., Heiland, D. H., Schnell, O., & Joseph, K. (2021). Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell death & disease, 12(8), 723. https://doi.org/10.1038/s41419-021-03937-9
Maier, Julian P, et al. "Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma." Cell death & disease vol. 12,8 (2021): 723. doi: https://doi.org/10.1038/s41419-021-03937-9
Maier JP, Ravi VM, Kueckelhaus J, Behringer SP, Garrelfs N, Will P, Sun N, von Ehr J, Goeldner JM, Pfeifer D, Follo M, Hannibal L, Walch AK, Hofmann UG, Beck J, Heiland DH, Schnell O, Joseph K. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell Death Dis. 2021 Jul 21;12(8):723. doi: 10.1038/s41419-021-03937-9. PMID: 34290229; PMCID: PMC8295384.
Copy Download .nbib Format: NLM
Der Pneumonie keine Chance geben.

Pflege

Lauffer-Vogt SU, Maier J.
PMID: 34445884
Pflege. 2021;34(6):329-336. doi: 10.1024/1012-5302/a000829. Epub 2021 Aug 27.

No chance for pneumonia - A campaign for mobilization in the context of a practice project addressing pneumonia prevention

Cite
Lauffer-Vogt SU, Maier J. Der Pneumonie keine Chance geben. Pflege. 2021;34(6):329-336doi: 10.1024/1012-5302/a000829.
Lauffer-Vogt, S. U., & Maier, J. (2021). Der Pneumonie keine Chance geben. Pflege, 34(6), 329-336. https://doi.org/10.1024/1012-5302/a000829
Lauffer-Vogt, Stefan Urs, and Maier, Jürgen. "Der Pneumonie keine Chance geben." Pflege vol. 34,6 (2021): 329-336. doi: https://doi.org/10.1024/1012-5302/a000829
Lauffer-Vogt SU, Maier J. Der Pneumonie keine Chance geben. Pflege. 2021;34(6):329-336. doi: 10.1024/1012-5302/a000829. Epub 2021 Aug 27. PMID: 34445884.
Copy Download .nbib Format: NLM
The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.

Contraception

Sinkey RG, Blanchard CT, Maier J, Novara A, Mazzoni SE, Goepfert AR, Boozer M, Rajapreyar I, Cribbs M, Szychowski JM, Tita ATN.
PMID: 34529951
Contraception. 2022 Jan;105:55-60. doi: 10.1016/j.contraception.2021.09.005. Epub 2021 Sep 14.

OBJECTIVE: To evaluate the effects of offering immediate postpartum long-acting reversible contraception to pregnant patients with heart disease.STUDY DESIGN: Retrospective cohort of pregnant patients with cardiac disease managed by a Comprehensive Pregnancy & Heart Program. Patients were divided into...

Cite
Sinkey RG, Blanchard CT, Maier J, et al. The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease. Contraception. 2021;105:55-60doi: 10.1016/j.contraception.2021.09.005.
Sinkey, R. G., Blanchard, C. T., Maier, J., Novara, A., Mazzoni, S. E., Goepfert, A. R., Boozer, M., Rajapreyar, I., Cribbs, M., Szychowski, J. M., & Tita, A. T. N. (2022). The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease. Contraception, 10555-60. https://doi.org/10.1016/j.contraception.2021.09.005
Sinkey, Rachel G, et al. "The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease." Contraception vol. 105 (2022): 55-60. doi: https://doi.org/10.1016/j.contraception.2021.09.005
Sinkey RG, Blanchard CT, Maier J, Novara A, Mazzoni SE, Goepfert AR, Boozer M, Rajapreyar I, Cribbs M, Szychowski JM, Tita ATN. The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease. Contraception. 2022 Jan;105:55-60. doi: 10.1016/j.contraception.2021.09.005. Epub 2021 Sep 14. PMID: 34529951.
Copy Download .nbib Format: NLM
Showing 457 to 461 of 461 entries